These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 2567781)
1. Issues in the use of depot antipsychotics. Middlemiss MA; Beeber LS J Psychosoc Nurs Ment Health Serv; 1989 Jun; 27(6):36-7. PubMed ID: 2567781 [No Abstract] [Full Text] [Related]
2. Facialis palsy attributable to depot antipsychotic therapy. Licina M; Tavcar R Can J Psychiatry; 2003 Nov; 48(10):712-3. PubMed ID: 14674060 [No Abstract] [Full Text] [Related]
3. Intramuscular preparations of antipsychotics: uses and relevance in clinical practice. Altamura AC; Sassella F; Santini A; Montresor C; Fumagalli S; Mundo E Drugs; 2003; 63(5):493-512. PubMed ID: 12600227 [TBL] [Abstract][Full Text] [Related]
4. Flupenthixol decanoate and injection site abscesses in an obese patient. Andrade C Aust N Z J Psychiatry; 2002 Aug; 36(4):561-2. PubMed ID: 12169162 [No Abstract] [Full Text] [Related]
6. Is depot medication safe in the setting of myopathy? Price JR; Bastiampillai T; Dhillon RS Aust N Z J Psychiatry; 2009 Aug; 43(8):781-3. PubMed ID: 19629801 [No Abstract] [Full Text] [Related]
7. [Technics for intramuscular injections of delayed-action neuroleptics]. Bélanger-Annable MC Infirm Can; 1985 Sep; 27(8):26-9. PubMed ID: 2863219 [No Abstract] [Full Text] [Related]
8. Injection of depot antipsychotic medications in patients with schizophrenia. Fleishman M J Clin Psychiatry; 2002 Sep; 63(9):840-1; author reply 841-2. PubMed ID: 12363128 [No Abstract] [Full Text] [Related]
9. The use of depot medications in the treatment of schizophrenia. Davis JM Am J Psychiatry; 2010 Feb; 167(2):125-6. PubMed ID: 20123919 [No Abstract] [Full Text] [Related]
10. Long-acting neuroleptics: technique for intramuscular injection. Bélanger-Annable MC Can Nurse; 1985 Sep; 81(8):41-3. PubMed ID: 2862986 [No Abstract] [Full Text] [Related]
11. Why change injection sites for depot antipsychotic medication? Cox A; Emmerson B; Collyer B; Scott J Aust N Z J Psychiatry; 2012 Aug; 46(8):794. PubMed ID: 22495954 [No Abstract] [Full Text] [Related]
12. Complications at site of injection of depot neuroleptics. Hay J BMJ; 1995 Aug; 311(7002):421. PubMed ID: 7640587 [No Abstract] [Full Text] [Related]
13. Long-term depot antipsychotics. A risk-benefit assessment. Barnes TR; Curson DA Drug Saf; 1994 Jun; 10(6):464-79. PubMed ID: 7917075 [TBL] [Abstract][Full Text] [Related]
14. Atypical Neuroleptic Malignant Syndrome Associated With Paliperidone Long-Acting Injection: A Case Report. Langley-DeGroot M; Joshi Y; Lehman D; Rao S J Clin Psychopharmacol; 2016 Jun; 36(3):277-9. PubMed ID: 27043124 [No Abstract] [Full Text] [Related]
15. [Depot antipsychotics in the year 2011]. Knegtering H; Oolders H; Ruijsink MA; van der Moolen AE Tijdschr Psychiatr; 2011; 53(2):95-105. PubMed ID: 21319066 [TBL] [Abstract][Full Text] [Related]
16. Predictors for starting depot administration of risperidone in chronic users of antipsychotics. Vehof J; Postma MJ; Bruggeman R; De Jong-Van Den Berg LT; Van Den Berg PB; Stolk RP; Burger H J Clin Psychopharmacol; 2008 Dec; 28(6):625-30. PubMed ID: 19011430 [TBL] [Abstract][Full Text] [Related]
17. A comparative study of depot injection techniques. Quartermaine S; Taylor R Nurs Times; 1995 Jul 26-Aug 1; 91(30):36-9. PubMed ID: 7644369 [TBL] [Abstract][Full Text] [Related]